Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

POSACONAZOLE DR 100 MG TABLET

Posaconazole Delayed-Release
$2.5082per EA

Strength

100 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135042960

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

POSACONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA212411

On Market Since

8/28/2019

Pharmacological Classes

Azole Antifungal
Azoles

Price History

1W

0.0%

1M

+2.9%

3M

-10.4%

6M

-29.8%

1Y

-35.1%

3Y

-68.7%

5Y

N/A

All

-73.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ATHLETE'S FOOT 2% POWDER SPRAY
Generic
70000032101•Cardinal Health
$0.0362
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126526•Rugby Laboratories
$0.0494
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122044427•AmerisourceBergen
$0.0579
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122078929•AmerisourceBergen
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000032301•Cardinal Health
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000067901•Cardinal Health
$0.0579
per GM
BAZA ANTIFUNGAL 2% CREAM
Generic
11701004514•Coloplast Manufacturing US, LLC
$0.0585
per GM
ATHLETE'S FOOT 1% CREAM
Generic
70000054202•Cardinal Health
$0.0614
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126595•Rugby Laboratories
$0.0639
per GM
ANTIFUNGAL 1% TOPICAL CREAM
Generic
00536127222•Rugby Laboratories
$0.0639
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy